Skip to main content
Equibles
SBC logo

SBC · SBC Medical Group Holdings Inc

Track SBC — free

Use SBC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.12 -0.16 (-3.74%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$440.18M
Shares
102.85M

SBC metrics

77 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.12
Market cap
$440.18M

Price action

19 metrics
Price change (1W)
+1.7%
Price change (30D)
+38.7%
Price change (3M)
+36.9%
Price change (6M)
+10.8%
Price change (YTD)
-4.4%
Price change (1Y)
+1.2%
Trailing year
Price change (5Y)
—
52-week high
$4.99
52-week low
$2.87
Change from 52-week high
-17.4%
Change from 52-week low
+43.6%
Annualized volatility
58.7%
Beta
0.6
RSI (14D)
63.3
Price vs SMA 50
+21.9%
Price vs SMA 200
+11.2%
Avg volume (3M)
137,151
Relative volume
1.0
Average dollar volume
$471,546

Company

3 metrics
Sector
Industrials
Industry
Consulting Services
Shares outstanding
102.85M

Valuation

12 metrics
P / E (TTM)
8.6
Trailing earnings · reciprocal yield 11.7%
PEG ratio
0.0
EV / revenue
1.7×
reciprocal yield 59.7%
EV / EBITDA
4.3×
reciprocal yield 23.4%
EV / EBIT
4.5×
reciprocal yield 22.3%
P / sales
2.5×
reciprocal yield 39.8%
P / book
1.7
reciprocal yield 59.9%
FCF yield
14.0%
TTM · current market cap
Buyback yield
—
P / FCF
7.1
reciprocal yield 14.0%
P / operating cash flow
7.0
reciprocal yield 14.3%
Earnings yield
11.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.3×
reciprocal yield 75.2%
EV / revenue historical average (5Y)
1.3×
reciprocal yield 75.2%
EV / EBIT historical average (3Y)
3.7×
reciprocal yield 27.3%
EV / EBIT historical average (5Y)
3.7×
reciprocal yield 27.3%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
71.9%
Operating margin
37.3%
Trailing 12 months
Net margin
28.0%
Gross profit (TTM)
$125.86M
Operating profit (TTM)
$65.41M
Net income (TTM)
$49.04M
Trailing 12 months
Diluted EPS (TTM)
$0.48
FCF margin
35.3%
Effective tax rate
33.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.51

Growth

11 metrics
Revenue growth YoY
+13.4%
Year over year
Net income growth YoY
+335.0%
Revenue (TTM)
$175.17M
Trailing 12 months
EPS growth YoY
+400.0%
Shares change YoY
-0.9%
Year over year · fewer shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
18.6%
Return on assets
12.1%
Debt / equity
0.1
Current ratio
3.3
EBITDA (TTM)
$68.63M
Free cash flow (TTM)
$61.77M
Quick ratio
3.3
Interest coverage
194.9
Net debt / EBITDA
-2.1
Return on invested capital
37.1%
Trailing 12 months
Net cash
$146.66M
Latest balance sheet
Cash & equivalents
$184.31M
Total assets
$406.66M
Total debt
$37.96M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$62.82M
Capital expenditures (TTM)
$1.05M
R&D (TTM)
—
SG&A (TTM)
$60.45M
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
74
13F filer change QoQ
+4
Institutional ownership
8.1%

Short interest

3 metrics
Short interest
0.7%
Latest settlement · 4.7 days to cover
Days to cover
4.7d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1930313 CUSIP 73245B107 13F (30d) 44 filings 44 filers Visit website Investor relations